Aprea Therapeutics, Inc. · NASDAQ:APRE
Vestal Point Capital, LP reported a 9.90% stake in Aprea Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Vestal Point Capital, LP reported a 9.90% stake in Aprea Therapeutics, Inc., 22,654,832 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 22,654,832
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 9.90% | 22,654,832 |
| Ryan Wilder | 9.90% | 22,654,832 |